Marine Oil from C. finmarchicus Enhances Glucose Homeostasis and Liver Insulin Resistance in Obese Prediabetic Individuals

The intermediate state between normal glucose tolerance and overt type 2 diabetes mellitus is associated with micro- and macrovascular diseases, requiring safe and cost-effective treatment measures interventions. A novel source of LC n-3 FAs is Calanus finmarchicus Oil, which showed promising effect...

Full description

Saved in:

Bibliographic Details
Published in:	Nutrients Vol. 14; no. 2; p. 396
Main Authors:	Burhop, Milena, Schuchardt, Jan Philipp, Nebl, Josefine, Müller, Mattea, Lichtinghagen, Ralf, Hahn, Andreas
Format:	Journal Article
Language:	English
Published:	Switzerland MDPI AG 17.01.2022 MDPI
Subjects:	Aged Animals blood glucose Blood Glucose - metabolism body composition Body Mass Index Calanus finmarchicus Chronic illnesses Copepoda - chemistry cost effectiveness Dietary Fats, Unsaturated - therapeutic use Double-Blind Method Energy intake Fatty Acids, Omega-3 - blood Female glucose glucose tolerance Homeostasis Humans Hyperglycemia insulin Insulin Resistance Kinases liver Liver - drug effects Liver - metabolism Male Middle Aged muscles noninsulin-dependent diabetes mellitus Obesity Obesity - drug therapy Obesity - metabolism oils Placebos Prediabetic State - drug therapy Prediabetic State - metabolism Germany marine oil inflammation glucose metabolism insulin resistance prediabetes intermediate hyperglycaemia
ISSN:	2072-6643, 2072-6643
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Abstract	The intermediate state between normal glucose tolerance and overt type 2 diabetes mellitus is associated with micro- and macrovascular diseases, requiring safe and cost-effective treatment measures interventions. A novel source of LC n-3 FAs is Calanus finmarchicus Oil, which showed promising effects on glucose homeostasis in preclinical studies due to anti-obesity effects and/or anti-inflammatory properties. In total, 43 obese patients (BMI: 31.7 ± 5.2 kg/m2) were allocated in the following two groups: (1) Calanus oil group (2 g CO/day) and (2) placebo group (2 g paraffin oil/day). Markers of glucose metabolism, body composition and energy intake were measured at the beginning (t0), after 12 weeks (t12) and 16 weeks (t16). Overall, parameters reflecting abnormal glucose homeostasis and insulin resistance in the liver, including fasting insulin (−2.9 mU/L ± 4.10, p < 0.05), HOMA-IR (−0.9 ± 1.28, p < 0.05) and hepatic insulin resistance index (−1.06 ± 1.72 × 106, p < 0.05) significantly enhanced after a 12-week CO-intervention, while no differences were observed in HbA1c, AUC0–2h Glucose, AUC0–2h Insulin, 2 h plasma glucose and muscle insulin sensitivity index. Our results indicate that Calanus oil causes beneficial effects on glucose metabolism and insulin resistance in obese patients, with clinical relevance to be verified in further studies. In addition, the possible active compounds and their mechanisms of action should be elucidated.
AbstractList	The intermediate state between normal glucose tolerance and overt type 2 diabetes mellitus is associated with micro- and macrovascular diseases, requiring safe and cost-effective treatment measures interventions. A novel source of LC n-3 FAs is Oil, which showed promising effects on glucose homeostasis in preclinical studies due to anti-obesity effects and/or anti-inflammatory properties. In total, 43 obese patients (BMI: 31.7 ± 5.2 kg/m ) were allocated in the following two groups: (1) Calanus oil group (2 g CO/day) and (2) placebo group (2 g paraffin oil/day). Markers of glucose metabolism, body composition and energy intake were measured at the beginning (t0), after 12 weeks (t ) and 16 weeks (t ). Overall, parameters reflecting abnormal glucose homeostasis and insulin resistance in the liver, including fasting insulin (-2.9 mU/L ± 4.10, < 0.05), HOMA-IR (-0.9 ± 1.28, < 0.05) and hepatic insulin resistance index (-1.06 ± 1.72 × 10 , < 0.05) significantly enhanced after a 12-week CO-intervention, while no differences were observed in HbA1c, AUC Glucose, AUC Insulin, 2 h plasma glucose and muscle insulin sensitivity index. Our results indicate that Calanus oil causes beneficial effects on glucose metabolism and insulin resistance in obese patients, with clinical relevance to be verified in further studies. In addition, the possible active compounds and their mechanisms of action should be elucidated. The intermediate state between normal glucose tolerance and overt type 2 diabetes mellitus is associated with micro- and macrovascular diseases, requiring safe and cost-effective treatment measures interventions. A novel source of LC n-3 FAs is Calanus finmarchicus Oil, which showed promising effects on glucose homeostasis in preclinical studies due to anti-obesity effects and/or anti-inflammatory properties. In total, 43 obese patients (BMI: 31.7 ± 5.2 kg/m2) were allocated in the following two groups: (1) Calanus oil group (2 g CO/day) and (2) placebo group (2 g paraffin oil/day). Markers of glucose metabolism, body composition and energy intake were measured at the beginning (t0), after 12 weeks (t12) and 16 weeks (t16). Overall, parameters reflecting abnormal glucose homeostasis and insulin resistance in the liver, including fasting insulin (-2.9 mU/L ± 4.10, p < 0.05), HOMA-IR (-0.9 ± 1.28, p < 0.05) and hepatic insulin resistance index (-1.06 ± 1.72 × 106, p < 0.05) significantly enhanced after a 12-week CO-intervention, while no differences were observed in HbA1c, AUC0-2h Glucose, AUC0-2h Insulin, 2 h plasma glucose and muscle insulin sensitivity index. Our results indicate that Calanus oil causes beneficial effects on glucose metabolism and insulin resistance in obese patients, with clinical relevance to be verified in further studies. In addition, the possible active compounds and their mechanisms of action should be elucidated.The intermediate state between normal glucose tolerance and overt type 2 diabetes mellitus is associated with micro- and macrovascular diseases, requiring safe and cost-effective treatment measures interventions. A novel source of LC n-3 FAs is Calanus finmarchicus Oil, which showed promising effects on glucose homeostasis in preclinical studies due to anti-obesity effects and/or anti-inflammatory properties. In total, 43 obese patients (BMI: 31.7 ± 5.2 kg/m2) were allocated in the following two groups: (1) Calanus oil group (2 g CO/day) and (2) placebo group (2 g paraffin oil/day). Markers of glucose metabolism, body composition and energy intake were measured at the beginning (t0), after 12 weeks (t12) and 16 weeks (t16). Overall, parameters reflecting abnormal glucose homeostasis and insulin resistance in the liver, including fasting insulin (-2.9 mU/L ± 4.10, p < 0.05), HOMA-IR (-0.9 ± 1.28, p < 0.05) and hepatic insulin resistance index (-1.06 ± 1.72 × 106, p < 0.05) significantly enhanced after a 12-week CO-intervention, while no differences were observed in HbA1c, AUC0-2h Glucose, AUC0-2h Insulin, 2 h plasma glucose and muscle insulin sensitivity index. Our results indicate that Calanus oil causes beneficial effects on glucose metabolism and insulin resistance in obese patients, with clinical relevance to be verified in further studies. In addition, the possible active compounds and their mechanisms of action should be elucidated. The intermediate state between normal glucose tolerance and overt type 2 diabetes mellitus is associated with micro- and macrovascular diseases, requiring safe and cost-effective treatment measures interventions. A novel source of LC n-3 FAs is Calanus finmarchicus Oil, which showed promising effects on glucose homeostasis in preclinical studies due to anti-obesity effects and/or anti-inflammatory properties. In total, 43 obese patients (BMI: 31.7 ± 5.2 kg/m2) were allocated in the following two groups: (1) Calanus oil group (2 g CO/day) and (2) placebo group (2 g paraffin oil/day). Markers of glucose metabolism, body composition and energy intake were measured at the beginning (t0), after 12 weeks (t12) and 16 weeks (t16). Overall, parameters reflecting abnormal glucose homeostasis and insulin resistance in the liver, including fasting insulin (−2.9 mU/L ± 4.10, p < 0.05), HOMA-IR (−0.9 ± 1.28, p < 0.05) and hepatic insulin resistance index (−1.06 ± 1.72 × 106, p < 0.05) significantly enhanced after a 12-week CO-intervention, while no differences were observed in HbA1c, AUC0–2h Glucose, AUC0–2h Insulin, 2 h plasma glucose and muscle insulin sensitivity index. Our results indicate that Calanus oil causes beneficial effects on glucose metabolism and insulin resistance in obese patients, with clinical relevance to be verified in further studies. In addition, the possible active compounds and their mechanisms of action should be elucidated. The intermediate state between normal glucose tolerance and overt type 2 diabetes mellitus is associated with micro- and macrovascular diseases, requiring safe and cost-effective treatment measures interventions. A novel source of LC n-3 FAs is Calanus finmarchicus Oil, which showed promising effects on glucose homeostasis in preclinical studies due to anti-obesity effects and/or anti-inflammatory properties. In total, 43 obese patients (BMI: 31.7 ± 5.2 kg/m²) were allocated in the following two groups: (1) Calanus oil group (2 g CO/day) and (2) placebo group (2 g paraffin oil/day). Markers of glucose metabolism, body composition and energy intake were measured at the beginning (t0), after 12 weeks (t₁₂) and 16 weeks (t₁₆). Overall, parameters reflecting abnormal glucose homeostasis and insulin resistance in the liver, including fasting insulin (−2.9 mU/L ± 4.10, p < 0.05), HOMA-IR (−0.9 ± 1.28, p < 0.05) and hepatic insulin resistance index (−1.06 ± 1.72 × 10⁶, p < 0.05) significantly enhanced after a 12-week CO-intervention, while no differences were observed in HbA1c, AUC₀–₂ₕ Glucose, AUC₀–₂ₕ Insulin, 2 h plasma glucose and muscle insulin sensitivity index. Our results indicate that Calanus oil causes beneficial effects on glucose metabolism and insulin resistance in obese patients, with clinical relevance to be verified in further studies. In addition, the possible active compounds and their mechanisms of action should be elucidated.
Author	Nebl, Josefine Burhop, Milena Hahn, Andreas Lichtinghagen, Ralf Müller, Mattea Schuchardt, Jan Philipp
AuthorAffiliation	1 Institute of Food Science and Human Nutrition, Leibniz University Hannover, 30167 Hannover, Germany; jan-philipp.schuchardt@lw.uni-hannover.de (J.P.S.); josefine_nebl@web.de (J.N.); mueller@nutrition.uni-hannover.de (M.M.); hahn@nutrition.uni-hannover.de (A.H.) 2 Institute for Clinical Chemistry, Hannover Medical School, 30625 Hannover, Germany; Lichtinghagen.Ralf@mh-hannover.de
AuthorAffiliation_xml	– name: 1 Institute of Food Science and Human Nutrition, Leibniz University Hannover, 30167 Hannover, Germany; jan-philipp.schuchardt@lw.uni-hannover.de (J.P.S.); josefine_nebl@web.de (J.N.); mueller@nutrition.uni-hannover.de (M.M.); hahn@nutrition.uni-hannover.de (A.H.) – name: 2 Institute for Clinical Chemistry, Hannover Medical School, 30625 Hannover, Germany; Lichtinghagen.Ralf@mh-hannover.de
Author_xml	– sequence: 1 givenname: Milena orcidid: 0000-0003-0017-3748 surname: Burhop fullname: Burhop, Milena – sequence: 2 givenname: Jan Philipp orcidid: 0000-0003-1724-6325 surname: Schuchardt fullname: Schuchardt, Jan Philipp – sequence: 3 givenname: Josefine surname: Nebl fullname: Nebl, Josefine – sequence: 4 givenname: Mattea orcidid: 0000-0002-3340-5122 surname: Müller fullname: Müller, Mattea – sequence: 5 givenname: Ralf surname: Lichtinghagen fullname: Lichtinghagen, Ralf – sequence: 6 givenname: Andreas orcidid: 0000-0001-8459-6582 surname: Hahn fullname: Hahn, Andreas
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/35057577$$D View this record in MEDLINE/PubMed
BookMark	eNqNkkFvFSEQx4mpsbX24gcwJF6Myass7AJ7MWleatvkmWeMngkLg49mFyosL9FPL5u2WhsPchkGfv9_ZmCeo4MQAyD0siGnjPXkXShNSyhhPX-CjigRdMV5yw4e7A_RSc7XZFmCCM6eoUPWkU50Qhyhnx918gHw1o_YpTjh9Sl2Pkw6mZ03JePzsNPBQMYXYzExA76ME8Q86-wz1sHijd9Dwlchl9EH_Bnq-bwocM22A1TFpwTW6wFmbypn_d7bosf8Aj11NcDJXTxGXz-cf1lfrjbbi6v12WZlWtbPKw0aHLiGA7cARpJG9P1Q6-ctAVebdGQwbW8Jt4OVllLXGCl1BxI6xwfOjtH7W9-bMkxgDYQ56VHdJF-7_KGi9urvm-B36lvcKykkkWwxeHNnkOL3AnlWk88GxlEHiCUrylspmaRC_AdKKZWCir6irx-h17GkUF9ioRrWcsZppV49LP531fc_WAFyC5gUc07glPGznn1cevGjaoha5kT9mZMqeftIcu_6D_gXYTG-0A
CitedBy_id	crossref_primary_10_3389_fphar_2022_1038730 crossref_primary_10_3390_metabo15090596 crossref_primary_10_3390_medicina58040472 crossref_primary_10_1002_lipd_12369 crossref_primary_10_3390_md23040139 crossref_primary_10_3390_life13061322 crossref_primary_10_1186_s12944_024_02207_9 crossref_primary_10_1002_fft2_480 crossref_primary_10_1016_j_nutres_2024_09_009 crossref_primary_10_3390_nu17101630 crossref_primary_10_1016_j_plipres_2024_101286 crossref_primary_10_3390_lipidology2020011 crossref_primary_10_1097_CRD_0000000000001048
Cites_doi	10.1016/j.diabres.2020.108233 10.1007/s40279-015-0366-z 10.1016/j.diabres.2007.05.004 10.1096/fj.201700442R 10.2337/dc08-S055 10.1038/nm0410-400 10.2337/dc06-1519 10.1371/journal.pone.0194127 10.3354/meps307273 10.1016/j.ypmed.2004.02.030 10.1002/biof.1277 10.3389/fphar.2020.00961 10.1186/1476-511X-11-105 10.1016/j.plefa.2017.01.009 10.1159/000484089 10.3390/nu12072139 10.1002/acr.20052 10.3390/nu12020481 10.3390/ijms21176275 10.1210/jc.2017-00185 10.1186/s12944-016-0303-7 10.2337/dc17-S005 10.1002/jcp.25855 10.1186/s12944-019-1048-x 10.1016/j.biochi.2020.08.015 10.1007/BF00280883 10.1016/j.mam.2017.09.001 10.3390/nu12051305 10.1016/j.phrs.2020.105113 10.1038/nature05482 10.1177/2047487319880041 10.1017/S0007114513001839 10.1016/j.yrtph.2016.05.030 10.1210/jc.2012-3056 10.1016/S0140-6736(12)60283-9 10.1016/j.aquaculture.2015.01.010 10.4103/0975-3583.70903 10.1001/archinternmed.2012.262 10.3390/ijms18071552 10.1002/clc.20604 10.1152/ajpcell.00123.2015 10.1016/j.atherosclerosis.2009.10.012 10.1016/j.jnutbio.2018.02.012 10.1042/BST20160474 10.1016/j.endinu.2018.08.003 10.3390/nu11071562 10.1007/s11883-008-0078-z 10.1016/j.clnu.2011.08.013 10.1210/clinem/dgaa630 10.5650/jos.ess18076
ContentType	Journal Article
Copyright	2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2022 by the authors. 2022
Copyright_xml	– notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2022 by the authors. 2022
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TS 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 7S9 L.6 5PM
DOI	10.3390/nu14020396
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Physical Education Index Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Physical Education Index ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic Publicly Available Content Database AGRICOLA CrossRef
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Anatomy & Physiology
EISSN	2072-6643
ExternalDocumentID	PMC8780836 35057577 10_3390_nu14020396
Genre	Randomized Controlled Trial Journal Article
GeographicLocations	Germany
GeographicLocations_xml	– name: Germany
GrantInformation_xml	– fundername: Calanus AS grantid: 60422304
GroupedDBID	--- 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAWTL AAYXX ABUWG ACIWK ACPRK AENEX AFFHD AFKRA AFRAH AFZYC ALMA_UNASSIGNED_HOLDINGS APEBS BENPR BPHCQ BVXVI CCPQU CITATION DIK E3Z EBD ECGQY EIHBH ESTFP EYRJQ F5P FYUFA GX1 HMCUK HYE IAO ITC KQ8 LK8 M1P M48 MODMG M~E OK1 OZF P2P P6G PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO RNS RPM TR2 UKHRP 3V. ALIPV ATCPS BBNVY BHPHI CGR CUY CVF ECM EIF GROUPED_DOAJ HCIFZ M0K M7P NPM 7TS 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 7S9 L.6 5PM
ID	FETCH-LOGICAL-c439t-aeaefef16e6deec801799b057640ef072f0bc49d06dbd8d22f1c88a5e8e5f6b63
IEDL.DBID	7X7
ISICitedReferencesCount	11
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000750558400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2072-6643
IngestDate	Tue Nov 04 01:46:36 EST 2025 Thu Oct 02 10:35:20 EDT 2025 Thu Sep 04 15:12:38 EDT 2025 Tue Oct 07 06:55:18 EDT 2025 Thu Jan 02 22:56:19 EST 2025 Tue Nov 18 22:28:49 EST 2025 Sat Nov 29 07:13:13 EST 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	2
Keywords	marine oil inflammation glucose metabolism insulin resistance prediabetes intermediate hyperglycaemia
Language	English
License	Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c439t-aeaefef16e6deec801799b057640ef072f0bc49d06dbd8d22f1c88a5e8e5f6b63
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 ObjectType-Undefined-3
ORCID	0000-0003-0017-3748 0000-0003-1724-6325 0000-0002-3340-5122 0000-0001-8459-6582
OpenAccessLink	https://www.proquest.com/docview/2621346362?pq-origsite=%requestingapplication%
PMID	35057577
PQID	2621346362
PQPubID	2032353
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_8780836 proquest_miscellaneous_2648838277 proquest_miscellaneous_2622287279 proquest_journals_2621346362 pubmed_primary_35057577 crossref_citationtrail_10_3390_nu14020396 crossref_primary_10_3390_nu14020396
PublicationCentury	2000
PublicationDate	20220117
PublicationDateYYYYMMDD	2022-01-17
PublicationDate_xml	– month: 1 year: 2022 text: 20220117 day: 17
PublicationDecade	2020
PublicationPlace	Switzerland
PublicationPlace_xml	– name: Switzerland – name: Basel
PublicationTitle	Nutrients
PublicationTitleAlternate	Nutrients
PublicationYear	2022
Publisher	MDPI AG MDPI
Publisher_xml	– name: MDPI AG – name: MDPI
References	Kwak (ref_9) 2012; 172 Schmidt (ref_49) 2012; 11 ref_12 ref_51 ref_19 Wang (ref_52) 2019; 18 Herder (ref_3) 2012; 379 Kakutani (ref_20) 2018; 67 Niederberger (ref_34) 2015; 45 Maurizi (ref_29) 2018; 233 Hingst (ref_33) 2018; 32 Harris (ref_26) 2004; 39 Derosa (ref_13) 2016; 42 Marik (ref_10) 2009; 32 Gellert (ref_48) 2017; 117 Lee (ref_18) 2006; 307 Mazaherioun (ref_41) 2017; 26 Lin (ref_42) 2016; 15 ref_27 (ref_36) 2019; 66 Tande (ref_23) 2016; 80 Kalupahana (ref_14) 2018; 58 Salma (ref_22) 2013; 110 Gerstein (ref_6) 2007; 78 Tocher (ref_16) 2015; 449 Harris (ref_8) 2008; 10 Akinkuolie (ref_15) 2011; 30 Nasr (ref_7) 2010; 1 Calder (ref_39) 2020; 178 Koc (ref_32) 2020; 105 ref_38 ref_37 Erion (ref_31) 2010; 16 Beulens (ref_28) 2019; 26 Anbazhagan (ref_43) 2016; 310 Schots (ref_17) 2020; 11 Matsuda (ref_25) 2007; 30 Calder (ref_11) 2017; 45 ref_47 ref_46 ref_1 Canas (ref_21) 2017; 102 ref_2 Matthews (ref_24) 1985; 28 Basu (ref_35) 2013; 98 Kahn (ref_30) 2006; 444 Pingali (ref_40) 2020; 13 ref_5 Yoshida (ref_50) 2010; 209 ref_4 Im (ref_44) 2018; 64 Kushner (ref_45) 2010; 62
References_xml	– ident: ref_5 doi: 10.1016/j.diabres.2020.108233 – volume: 45 start-page: 1497 year: 2015 ident: ref_34 article-title: Activation of AMPK and its Impact on Exercise Capacity publication-title: Sports Med. doi: 10.1007/s40279-015-0366-z – volume: 78 start-page: 305 year: 2007 ident: ref_6 article-title: Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies publication-title: Diabetes Res. Clin. Pract. doi: 10.1016/j.diabres.2007.05.004 – volume: 32 start-page: 1741 year: 2018 ident: ref_33 article-title: AMPK in skeletal muscle function and metabolism publication-title: FASEB J. doi: 10.1096/fj.201700442R – ident: ref_1 doi: 10.2337/dc08-S055 – volume: 16 start-page: 400 year: 2010 ident: ref_31 article-title: Diacylglycerol-mediated insulin resistance publication-title: Nat. Med. doi: 10.1038/nm0410-400 – volume: 30 start-page: 89 year: 2007 ident: ref_25 article-title: Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test publication-title: Diabetes Care doi: 10.2337/dc06-1519 – ident: ref_37 doi: 10.1371/journal.pone.0194127 – volume: 307 start-page: 273 year: 2006 ident: ref_18 article-title: Lipid storage in marine zooplankton publication-title: Mar. Ecol. Prog. Ser. doi: 10.3354/meps307273 – volume: 39 start-page: 212 year: 2004 ident: ref_26 article-title: The Omega-3 Index: A new risk factor for death from coronary heart disease? publication-title: Prev. Med. doi: 10.1016/j.ypmed.2004.02.030 – volume: 42 start-page: 316 year: 2016 ident: ref_13 article-title: Effects of n-3 pufas on fasting plasma glucose and insulin resistance in patients with impaired fasting glucose or impaired glucose tolerance publication-title: BioFactors doi: 10.1002/biof.1277 – volume: 13 start-page: 31 year: 2020 ident: ref_40 article-title: Evaluation of the Effect of Fish Oil Alone and in Combination with a Proprietary Chromium Complex on Endothelial Dysfunction, Systemic Inflammation and Lipid Profile in Type 2 Diabetes Mellitus—A Randomized, Double-Blind, Placebo-Controlled Clinical Study, Diabetes publication-title: Metab. Syndr. Obes. Targets Ther. – volume: 11 start-page: 961 year: 2020 ident: ref_17 article-title: Possible Health Effects of a Wax Ester Rich Marine Oil publication-title: Front. Pharmacol. doi: 10.3389/fphar.2020.00961 – volume: 11 start-page: 105 year: 2012 ident: ref_49 article-title: Different gene expression profiles in normo- and dyslipidemic men after fish oil supplementation: Results from a randomized controlled trial publication-title: Lipids Health Dis. doi: 10.1186/1476-511X-11-105 – volume: 117 start-page: 54 year: 2017 ident: ref_48 article-title: Low long chain omega-3 fatty acid status in middle-aged women publication-title: Prostaglandins Leukot. Essent. Fat. Acids doi: 10.1016/j.plefa.2017.01.009 – volume: 26 start-page: 535 year: 2017 ident: ref_41 article-title: Beneficial Effects of n-3 Fatty Acids on Cardiometabolic and Inflammatory Markers in Type 2 Diabetes Mellitus: A Clinical Trial publication-title: Med. Princ. Pract. doi: 10.1159/000484089 – ident: ref_46 doi: 10.3390/nu12072139 – ident: ref_27 – volume: 62 start-page: 442 year: 2010 ident: ref_45 article-title: A unifying biologic explanation for “high-sensitivity” C-reactive protein and “low-grade” inflammation publication-title: Arthritis Care Res. doi: 10.1002/acr.20052 – ident: ref_47 doi: 10.3390/nu12020481 – ident: ref_38 doi: 10.3390/ijms21176275 – volume: 102 start-page: 1983 year: 2017 ident: ref_21 article-title: Effects of Mixed Carotenoids on Adipokines and Abdominal Adiposity in Children: A Pilot Study publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2017-00185 – volume: 15 start-page: 133 year: 2016 ident: ref_42 article-title: What is the impact of n-3 PUFAs on inflammation markers in Type 2 diabetic mellitus populations?: A systematic review and meta-analysis of randomized controlled trials publication-title: Lipids Health Dis. doi: 10.1186/s12944-016-0303-7 – ident: ref_4 doi: 10.2337/dc17-S005 – volume: 233 start-page: 88 year: 2018 ident: ref_29 article-title: Adipocytes properties and crosstalk with immune system in obesity-related inflammation publication-title: J. Cell. Physiol. doi: 10.1002/jcp.25855 – volume: 18 start-page: 106 year: 2019 ident: ref_52 article-title: A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: A randomized and controlled clinical trial publication-title: Lipids Health Dis. doi: 10.1186/s12944-019-1048-x – volume: 178 start-page: 105 year: 2020 ident: ref_39 article-title: Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake publication-title: Biochimie doi: 10.1016/j.biochi.2020.08.015 – volume: 28 start-page: 412 year: 1985 ident: ref_24 article-title: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia doi: 10.1007/BF00280883 – volume: 64 start-page: 92 year: 2018 ident: ref_44 article-title: FFA4 (GPR120) as a fatty acid sensor involved in appetite control, insulin sensitivity and inflammation regulation publication-title: Mol. Asp. Med. doi: 10.1016/j.mam.2017.09.001 – ident: ref_2 doi: 10.3390/nu12051305 – ident: ref_51 doi: 10.1016/j.phrs.2020.105113 – volume: 444 start-page: 840 year: 2006 ident: ref_30 article-title: Mechanisms linking obesity to insulin resistance and type 2 diabetes publication-title: Nature doi: 10.1038/nature05482 – volume: 26 start-page: 47 year: 2019 ident: ref_28 article-title: Risk and management of pre-diabetes publication-title: Eur. J. Prev. Cardiol. doi: 10.1177/2047487319880041 – volume: 110 start-page: 2186 year: 2013 ident: ref_22 article-title: Oil from the marine zooplankton Calanus finmarchicus improves the cardiometabolic phenotype of diet-induced obese mice publication-title: Br. J. Nutr. doi: 10.1017/S0007114513001839 – volume: 80 start-page: 25 year: 2016 ident: ref_23 article-title: Clinical safety evaluation of marine oil derived from Calanus finmarchicus publication-title: Regul. Toxicol. Pharmacol. doi: 10.1016/j.yrtph.2016.05.030 – volume: 98 start-page: E409 year: 2013 ident: ref_35 article-title: Pathogenesis of prediabetes: Role of the liver in isolated fasting hyperglycemia and combined fasting and postprandial hyperglycemia publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2012-3056 – volume: 379 start-page: 2279 year: 2012 ident: ref_3 article-title: Prediabetes: A high-risk state for diabetes development publication-title: Lancet doi: 10.1016/S0140-6736(12)60283-9 – volume: 449 start-page: 94 year: 2015 ident: ref_16 article-title: Omega-3 long-chain polyunsaturated fatty acids and aquaculture in perspective publication-title: Aquaculture doi: 10.1016/j.aquaculture.2015.01.010 – volume: 1 start-page: 116 year: 2010 ident: ref_7 article-title: Silent myocardial ischemia in prediabetics in relation to insulin resistance publication-title: J. Cardiovasc. Dis. Res. doi: 10.4103/0975-3583.70903 – volume: 172 start-page: 686 year: 2012 ident: ref_9 article-title: Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: A meta-analysis of randomized, double-blind, placebo-controlled trials publication-title: Arch. Intern. Med. doi: 10.1001/archinternmed.2012.262 – ident: ref_12 doi: 10.3390/ijms18071552 – volume: 32 start-page: 365 year: 2009 ident: ref_10 article-title: Omega-3 dietary supplements and the risk of cardiovascular events: A systematic review publication-title: Clin. Cardiol. doi: 10.1002/clc.20604 – volume: 310 start-page: C612 year: 2016 ident: ref_43 article-title: A novel anti-inflammatory role of GPR120 in intestinal epithelial cells, American journal of physiology publication-title: Cell Physiol. doi: 10.1152/ajpcell.00123.2015 – volume: 209 start-page: 520 year: 2010 ident: ref_50 article-title: Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2009.10.012 – volume: 58 start-page: 1 year: 2018 ident: ref_14 article-title: Omega-3 fatty acids in obesity and metabolic syndrome: A mechanistic update publication-title: J. Nutr. Biochem. doi: 10.1016/j.jnutbio.2018.02.012 – volume: 45 start-page: 1105 year: 2017 ident: ref_11 article-title: Omega-3 fatty acids and inflammatory processes: From molecules to man publication-title: Biochem. Soc. Trans. doi: 10.1042/BST20160474 – volume: 66 start-page: 140 year: 2019 ident: ref_36 article-title: Obesidad y diabetes mellitus tipo 2: También unidas en opciones terapéuticas publication-title: Endocrinol. Diabetes Y Nutr. doi: 10.1016/j.endinu.2018.08.003 – ident: ref_19 doi: 10.3390/nu11071562 – volume: 10 start-page: 503 year: 2008 ident: ref_8 article-title: Intakes of long-chain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults publication-title: Curr. Atheroscler. Rep. doi: 10.1007/s11883-008-0078-z – volume: 30 start-page: 702 year: 2011 ident: ref_15 article-title: Omega-3 polyunsaturated fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials publication-title: Clin. Nutr. doi: 10.1016/j.clnu.2011.08.013 – volume: 105 start-page: e4510 year: 2020 ident: ref_32 article-title: Exercise Training Reduces Inflammation of Adipose Tissue in the Elderly: Cross-Sectional and Randomized Interventional Trial publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/clinem/dgaa630 – volume: 67 start-page: 1149 year: 2018 ident: ref_20 article-title: Effect of Oral Paprika Xanthophyll Intake on Abdominal Fat in Healthy Overweight Humans: A Randomized, Double-blind, Placebo-controlled Study publication-title: J. Oleo Sci. doi: 10.5650/jos.ess18076
SSID	ssj0000070763
Score	2.3583753
Snippet	The intermediate state between normal glucose tolerance and overt type 2 diabetes mellitus is associated with micro- and macrovascular diseases, requiring safe...
SourceID	pubmedcentral proquest pubmed crossref
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source
StartPage	396
SubjectTerms	Aged Animals blood glucose Blood Glucose - metabolism body composition Body Mass Index Calanus finmarchicus Chronic illnesses Copepoda - chemistry cost effectiveness Dietary Fats, Unsaturated - therapeutic use Double-Blind Method Energy intake Fatty Acids, Omega-3 - blood Female glucose glucose tolerance Homeostasis Humans Hyperglycemia insulin Insulin Resistance Kinases liver Liver - drug effects Liver - metabolism Male Middle Aged muscles noninsulin-dependent diabetes mellitus Obesity Obesity - drug therapy Obesity - metabolism oils Placebos Prediabetic State - drug therapy Prediabetic State - metabolism
Title	Marine Oil from C. finmarchicus Enhances Glucose Homeostasis and Liver Insulin Resistance in Obese Prediabetic Individuals
URI	https://www.ncbi.nlm.nih.gov/pubmed/35057577 https://www.proquest.com/docview/2621346362 https://www.proquest.com/docview/2622287279 https://www.proquest.com/docview/2648838277 https://pubmed.ncbi.nlm.nih.gov/PMC8780836
Volume	14
WOSCitedRecordID	wos000750558400001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2072-6643 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000070763 issn: 2072-6643 databaseCode: M~E dateStart: 20090101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2072-6643 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000070763 issn: 2072-6643 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2072-6643 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000070763 issn: 2072-6643 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2072-6643 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000070763 issn: 2072-6643 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELag5cAFKIWy0FZGICQOoY7dtZ0TaqstVGqXqAJpOUWxM1Yjtd6y2UWCX4_HyaYPUC9cEkWeSJZmxp7nN4S8tZkFYYICaoMtOakzScatSKxQlrHSgXQRMv9Yjcd6MsnyLuDWdGWVyzMxHtTV1GKMfIdLxB6T4bz9ePkjwalRmF3tRmjcJ6s4NhvlXE1UH2OJWDZStKikInj3O36RosMkEKP_-j30l3F5u0by2qVz-Ph_t_uEPOrMTbrXyscauQf-KVnf88HVvvhF39FYABoj6-vk90mJrYD0S31OseuEHnygrvYXMddgFw0d-TOUkYZ-auvcKc5YnwbzsqkbWvqKHmORBz1qy9vpKTRonIY_aPjCCQRA8xm00d7aBrplL1jzjHw7HH09-Jx0oxkSGyyYeVJCCQ5cKkFWAFajXmcm2H5yl4Fjijtm7G5WMVmZSlecu9RqXQ5Bw9BJI8VzsuKnHl4QypzRVnKWMSsxzWqYU1yADpZQOQzm1YC8XzKqsB1uOY7POC-C_4JMLa6YOiBvetrLFq3jn1SbS54VncY2xRXDBuR1vxx0DRMopYfpItLw4GFyld1FE45EoblSA7LRilC_FRG9QVxRN4SrJ0Cs75srvj6LmN9aacQRf3n31l-RhxzbM1iapGqTrMxnC9giD-zPed3MtqNyxKfeJqv7o3F-Gt750Un-_Q8saCD6
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VgkQvvAp0oYARD4lDqGN3beeAUFVauup2qVCR9hYSx1YjtU7Z7ILKj-I34nE2aQuotx44Rp5ElvN5POOZ-QbgpU604bnfgCrHkpzY5lHCNI80l5rSzBphA2X-UI5GajxO9hfgV1sLg2mVrU4MirqoNN6RrzGB3GPC69v3J98i7BqF0dW2hUYDi11z-sO7bPW7wQf_f18xtr11sLkTzbsKRNofvtMoM5mxxsbCiMIYrRCSSe7NFrFOjaWSWZrr9aSgosgLVTBmY61U1jfK9K3IBfffvQbXvR6X6OzJsezudAJ3juANCyrnCV1zsxgdNI49Ac6fe38Zs3_mZJ475LZv_2_Lcwduzc1pstHg_y4sGHcPljdcNq2OT8lrEhJcQ-RgGX7uZVjqSD6VRwSrasjmW2JLdxxiKXpWky13iHugJh-bPH6CPeQrbz7XZU0yV5AhJrGQQZO-Tz6bGo1v_wbxT9hhwZD9iWlus0vt5dpat_o-fLmSVXgAi65yZgUItbnSgtGEaoFh5JxaybhR3tLL-t587MGbFhipnvOyY3uQo9T7Zwii9AxEPXjRyZ40bCT_lFptMZLONVKdngGkB8-7Ya9LMECUOVPNggzzHjSTyWUyXuVzxaTswcMGst1UePB2cUReAHMngFzmF0dceRg4zZVUyJP-6PKpP4ObOwd7w3Q4GO0-hiWGpSg0jmK5CovTycw8gRv6-7SsJ0_DxiTw9aqh_hupcH0E
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLUJceJXHQgEjHhKHsI69azsHhKq2C6tulwhRqZxC4thqpDYpm11Q-Wn8Ojx5tQXUWw8cI08iy_k8nvHMfAPwQgfa8MRtQJVgSY5vEy9gmnuaS01pbI2wFWX-VM5man8_CFfgV1sLg2mVrU6sFHVaaLwjHzCB3GPC6duBbdIiwq3xu-NvHnaQwkhr206jhsiOOfnh3Lfy7WTL_euXjI23P29-8JoOA552B_HCi01srLG-MCI1RiuEZ5A4E0YMqbFUMksTPQxSKtIkVSlj1tdKxSOjzMiKRHD33Suw6kzyIevBajjZDb90NzwVk47gNScq5wEd5Esf3TWOHQLOnoJ_mbZ_ZmieOfLGN__nxboFNxpDm2zUO-M2rJj8Dqxt5PGiODohr0iV-lrFFNbg526MRZDkY3ZIsN6GbL4hNsuPqiiLXpZkOz_A3VGS93WGP8Hu8oUzrMusJHGekimmt5BJndhPPpkSzXL3BnFP2HvBkHBu6nvuTDu5tgquvAt7l7IK96CXF7l5AITaRGnBaEC1wABzQq1k3ChnA8YjZ1j24XULkkg3jO3YOOQwcp4bAio6BVQfnneyxzVPyT-l1lu8RI2uKqNTsPThWTfstAyGjuLcFMtKhjnfmsngIhl3GHDFpOzD_Rq-3VR45QfjiDwH7E4AWc7Pj-TZQcV2rqRCBvWHF0_9KVxzCI-mk9nOI7jOsEaF-p4v16G3mC_NY7iqvy-ycv6k2aUEvl421n8DLU6HUw
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Marine+Oil+from+C.+finmarchicus+Enhances+Glucose+Homeostasis+and+Liver+Insulin+Resistance+in+Obese+Prediabetic+Individuals&rft.jtitle=Nutrients&rft.au=Burhop%2C+Milena&rft.au=Schuchardt%2C+Jan+Philipp&rft.au=Nebl%2C+Josefine&rft.au=M%C3%BCller%2C+Mattea&rft.date=2022-01-17&rft.pub=MDPI&rft.eissn=2072-6643&rft.volume=14&rft.issue=2&rft_id=info:doi/10.3390%2Fnu14020396&rft_id=info%3Apmid%2F35057577&rft.externalDocID=PMC8780836
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6643&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6643&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6643&client=summon